180 related articles for article (PubMed ID: 23658415)
1. Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer.
Doi H; Beppu N; Odawara S; Tanooka M; Takada Y; Niwa Y; Fujiwara M; Kimura F; Yanagi H; Yamanaka N; Kamikonya N; Hirota S
J Radiat Res; 2013 Nov; 54(6):1118-24. PubMed ID: 23658415
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
3. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
5. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer.
Coucke PA; Sartorelli B; Cuttat JF; Jeanneret W; Gillet M; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):181-8. PubMed ID: 7721615
[TBL] [Abstract][Full Text] [Related]
6. Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis.
Qiaoli W; Yongping H; Wei X; Guoqiang X; Yunhe J; Qiuyan L; Cheng L; Mengling G; Jiayi L; Wei X; Yi Y
Int J Colorectal Dis; 2019 Dec; 34(12):2171-2183. PubMed ID: 31745621
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.
Marsh Rde W; George TJ; Siddiqui T; Mendenhall WM; Zlotecki RA; Grobmyer S; Hochwald S; Chang M; Larson B; King J
Am J Clin Oncol; 2010 Jun; 33(3):251-6. PubMed ID: 19823074
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.
Pach R; Kulig J; Richter P; Gach T; Szura M; Kowalska T
Langenbecks Arch Surg; 2012 Jun; 397(5):801-7. PubMed ID: 22170083
[TBL] [Abstract][Full Text] [Related]
9. Tumor regression grading after preoperative hyperfractionated radiotherapy/chemoradiotherapy for locally advanced rectal cancers: interim analysis of phase III clinical study.
Idasiak A; Galwas-Kliber K; Rajczykowski M; Dębosz-Suwińska I; Zeman M; Stobiecka E; Mrochem-Kwarciak J; Suwiński R
Neoplasma; 2021 May; 68(3):631-637. PubMed ID: 33618522
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
14. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.
Sterzing F; Hoehle F; Ulrich A; Jensen A; Debus J; Muenter M
J Radiat Res; 2015 Jan; 56(1):169-76. PubMed ID: 25341424
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer.
Suwinski R; Wydmanski J; Pawełczyk I; Starzewski J
Radiother Oncol; 2006 Jul; 80(1):27-32. PubMed ID: 16730087
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study.
Idasiak A; Galwas-Kliber K; Behrendt K; Wziętek I; Kryj M; Stobiecka E; Chmielik E; Suwiński R
Br J Radiol; 2017 Jun; 90(1074):20160731. PubMed ID: 28466686
[TBL] [Abstract][Full Text] [Related]
17. Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life.
Ciammella P; Ruggieri MP; Galeandro M; D'Abbiero N; Giunta A; Iotti C
Radiol Med; 2013 Dec; 118(8):1397-411. PubMed ID: 23801387
[TBL] [Abstract][Full Text] [Related]
18. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.
Velenik V; Oblak I; Anderluh F
Radiat Oncol; 2010 Sep; 5():88. PubMed ID: 20920276
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
